Orforglipron: who sells it, COA checklist and US status
28 online research vendors and 2 clinics, telehealth services and pharmacies list Orforglipron. Verified businesses are listed first; everyone else is alphabetical or by public review count, never ranked by us. Nothing here is medical or dosing advice. How verification works.
What Orforglipron is
Orforglipron is a small molecule, non peptide GLP-1 receptor agonist that is taken by mouth. It was developed by Eli Lilly.
Because it is described as non peptide, it differs in kind from peptide compounds. Its oral form also shapes which lab tests and label details apply to a product.
US regulatory status
As of November 18, 2026, FDA's Novel drug list for 2026 includes Foundayo (orforglipron), dated April 1, 2026.
That status is a summary as of November 18, 2026. Readers should check the FDA pages linked below for the current status.
Sources (checked Nov 18, 2026):
- FDA, Novel drug list for 2026, Nov 18, 2026
What a complete COA for Orforglipron shows
A complete certificate of analysis (COA) for orforglipron should name the testing lab and give contact details, so a reader can reach the lab directly. It should show a batch or lot number that matches the number printed on the product label. It should also show the test date. The site counts a COA older than 12 months as out of date.
The COA should confirm identity by mass spectrometry, with the measured mass matching the expected molecular weight of orforglipron. It should report high performance liquid chromatography (HPLC) results showing how much of the sample is orforglipron, with the chromatogram included so the result can be read rather than only stated as a percentage. It should also report the measured quantity per container and compare that figure with the quantity on the label.
Orforglipron is an oral product, so endotoxin (LAL) and sterility testing, which are tied to injectable products, generally do not apply. A COA for an oral form is not incomplete just because those results are absent. Anyone holding a COA can ask the lab to confirm that it is genuine, by giving the lab the batch or lot number and the report date. A lab that will not confirm its own report is a reason for caution.
Labs on verified Orforglipron COAs: lab names appear here once a verified business's Orforglipron COAs are confirmed with the issuing lab. How we confirm COAs.
What the label should show
A research vendor's label for orforglipron should show the compound name and the salt form if there is one, the quantity per container, a batch or lot number that matches the COA, a manufacture or expiry date, storage conditions, and the words "for research use only".
A pharmacy-dispensed prescription label looks different. It should show the patient's name, the prescriber, the pharmacy name and license details, the drug name and strength, the directions as written by the prescriber, and the fill date. These are different products sold under different rules, so a label from one kind of seller should not be read as if it came from the other.
Who lists Orforglipron
30 online research vendors list orforglipron on LegitPepCheck. They sell products labeled for research use only. Listings are not rankings. Verified businesses appear first. Not Verified does not mean unsafe.
Online research vendors (sold for research use only)
Clinics, telehealth and pharmacies (prescription, from licensed providers)
These businesses provide prescription products through licensed prescribers and pharmacists; research use only labeling does not apply to them. Local listings are businesses whose own website mentions Orforglipron; we have not confirmed what they offer.
Facts on this page come from the sources named, each with its date. LegitPepCheck does not give medical, dosing or purchasing advice. Not Verified means a business has not completed our review, not that it is unsafe.